Mirdametinib 1 mg, 2mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 1 mg, 2mg
Reference Brands: Gomekli (USA), Ezmekly (EU/UK)
Category: Oncology Cancer Care
Mirdametinib is an orally administered small-molecule inhibitor of MEK1 and MEK2 (part of the RAS/RAF/MEK/ERK signalling pathway). It is indicated for the treatment of patients (2 years and older) with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that cannot be completely removed by surgery.
Mirdametinib — third party manufacturing & bulk supply
Mirdametinib 1 mg, 2mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Mirdametinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Mirdametinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Mirdametinib →Frequently Asked Questions
Mirdametinib is used for the treatment of adults and children aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. It helps shrink tumor size and relieve symptoms such as pain and functional impairment.
Mirdametinib is made from the active compound mirdametinib, a synthetic small-molecule inhibitor of MEK1 and MEK2 enzymes, which are part of the MAPK signaling pathway involved in cell growth and differentiation.
The trade name of Mirdametinib is Gomekli.
Mirdametinib is manufactured by SpringWorks Therapeutics, Inc.
The generic name of this product is Mirdametinib.
The brand name is Gomekli.
Mirdametinib is manufactured in the United States by SpringWorks Therapeutics under approved regulatory standards.
Related Products
Afatinib
Strength:
20 mg, 30mg, 40 mg
Form: Tablets
Reference Brands: Gilotrif (USA), Giotrif (EU/UK)
View Details
Obinutuzumab
Strength:
25 mg/mL
Form: Injection
Reference Brands: Gazyva (USA), Gazyvaro (EU/UK)
View Details
Zongertinib
Strength:
60 mg, 90 mg, 120mg
Form: Tablets
Reference Brands: Hernexeos (USA)
View Details
Rucaparib Camsylate
Strength:
200 mg, 250 mg, 300 mg
Form: Oral tablets
Reference Brands: Rubraca® (EU & US)
View Details
Rituximab
Strength:
IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL
Form: IV Infusion; Subcutaneous
Reference Brands: Rituxan®(US), MabThera®, Truxima®(EU);Ruxience®(US)
View Details
Acalabrutinib
Strength:
100 mg
Form: Oral Capsules
Reference Brands: Calquence® (EU & US)
View Details
Venetoclax
Strength:
10 mg, 50 mg, 100 mg
Form: Tablet
Reference Brands: Venclexta® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
